{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:01:17Z","timestamp":1776816077043,"version":"3.51.2"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1366,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1365-2133.2011.10591.x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T12:44:01Z","timestamp":1315313041000},"page":"422-424","source":"Crossref","is-referenced-by-count":38,"title":["Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing"],"prefix":"10.1093","volume":"166","author":[{"given":"L.","family":"Feldmeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.F.L.","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"B\u00f6ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.E.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,12,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature08996","article-title":"Opposing roles for calcineurin and ATF3 in squamous skin cancer","volume":"465","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB2|cit2","first-page":"407","article-title":"Swiss clinical practice guidelines for skin cancer in organ transplant recipients","volume":"139","author":"Hofbauer","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.2004.00188.x","article-title":"Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies","volume":"18","author":"Mathew","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2007.08.014","article-title":"Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation","volume":"27","author":"Zuckermann","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2\u2003years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.transproceed.2008.09.038","article-title":"Use of everolimus in de novo renal recipients: initial experience in the Greek population","volume":"40","author":"Papanikolaou","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11255-009-9601-6","article-title":"Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors","volume":"42","author":"Srivastava","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1600-6143.2006.01282.x","article-title":"Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients","volume":"6","author":"Kuppahally","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.transproceed.2008.09.021","article-title":"Adverse effects of mammalian target of rapamycin inhibitors during the postoperative period after cardiac transplantation","volume":"40","author":"Bouzas-Mosquera","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2133.2011.10591.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0b013e3181aa7d87","article-title":"Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus","volume":"88","author":"Albano","year":"2009","journal-title":"Transplantation"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10591.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10591.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:53:20Z","timestamp":1676382800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/2\/422\/6613621"}},"subtitle":["mTOR inhibitors impair wound healing"],"short-title":[],"issued":{"date-parts":[[2011,12,5]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10591.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,5]]}}}